Spectral Diagnostics Inc. (OTCMKTS:EDTXF) Sees Significant Increase in Short Interest

Spectral Diagnostics Inc. (OTCMKTS:EDTXF) saw a large increase in short interest in July. As of July 31st, there was short interest totaling 29,285 shares, an increase of 369.2% from the July 15th total of 6,242 shares. Based on an average daily trading volume, of 21,150 shares, the short-interest ratio is currently 1.4 days. Approximately 0.0% of the company’s stock are sold short.

Spectral Diagnostics Price Performance

Shares of OTCMKTS:EDTXF opened at $1.00 on Wednesday. The company has a market cap of $295.02 million, a P/E ratio of -10.05 and a beta of 0.13. Spectral Diagnostics has a 1 year low of $0.59 and a 1 year high of $1.31. The stock’s fifty day moving average price is $0.97 and its 200-day moving average price is $0.98.

About Spectral Diagnostics

Spectral Medical Inc focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, and internationally. The company markets Endotoxin Activity Assay, a rapid in vitro diagnostic test for the detection of components of gram negative bacterial cell wall; and Polymyxin B Hemoperfusion, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream. It also develops and manufactures monoclonal and polyclonal antibodies, recombinant cardiac proteins, and calibrators for use in the research and development, as well as products that are manufactured by other diagnostic companies.